Upexi, Inc. Insider Trading Activity

Accepted by SEC EDGAR 07/24/2025 - 04:05 PM EDT Learn about SEC filing dates

Insider Trade Summary

Net Buyer: 16,000 shares

Net Buy 6 txns

Insider Dugan Lawrence

Role Director

Bought 16,000 shs ($98K)

Increase in Position 15.9%

Type	Security	Shares	Price	Value
Purchase	Common Stock	4,000	$7.50	$30K
Grant/Award	Common Stock	50,000	$0.00	$0.00
Grant/Award	Common Stock	50,000	$0.00	$0.00
Purchase	Common Stock	10,000	$5.70	$57K
Purchase	Common Stock	1,000	$5.60	$6K
Purchase	Common Stock	1,000	$5.17	$5K

Holdings After Transaction: Common Stock — 116,389 shares (Direct)

Holdings Before and After: Common Stock, 389 to 116,389 shares (Direct)

Other Insiders: 1 other insider reported open-market purchases of this stock in the 30 days up to this filing.

Footnotes (3)

1. F1. Vests in full 90 days from July 1, 2025.
2. F2. Vests quarterly in equal installments over 12 months beginning July 1, 2025.
3. F3. The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Dugan Lawrence

(Last) (First) (Middle)

3030 NORTH ROCKY POINT DRIVE

SUITE 420

(Street)

TAMPA FL 33607

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UPEXI, INC. [ UPXI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/15/2025		P		1,000	A	$5.17	1,389	D
Common Stock	07/16/2025		A		50,000(1)(3)	A	$0	51,389	D
Common Stock	07/16/2025		A		50,000(2)(3)	A	$0	101,389	D
Common Stock	07/16/2025		P		10,000	A	$5.7	111,389	D
Common Stock	07/16/2025		P		1,000	A	$5.6	112,389	D
Common Stock	07/22/2025		P		4,000	A	$7.5	116,389	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Vests in full 90 days from July 1, 2025.

2. Vests quarterly in equal installments over 12 months beginning July 1, 2025.

3. The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan.

Remarks:

	/s/ Lawrence Dugan	07/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.